In January 2021, in addition to revising the Self-Care Advertising Code (see our article here), the Irish Pharmaceutical Healthcare Association (IPHA) released the latest edition (edition 8.5) of its Code of Practice for the Pharmaceutical Industry (Code), which will take effect on 1 March 2021 and applies to prescription-only medicines.
Various scandals within the pharmaceutical industry over the last few years involving pharmaceutical companies, doctors and hospitals, sparked a push to strengthen the existing Code.
In our briefing we cover:
- Key Changes
- Inclusion of the EFPIA Ethical Principles
- Transfers of Value Disclosures
- Further Requirements Regarding Patient Organisation (PO) Funding
- Definitions
- Other Key Changes
- Effect of the Code
Please click here or on the image below to download our briefing.
Contributed by Florence Meagher & Louise Murray
Recommended Insights
Article and Insights
8
Aug 2023
The Irish M&A market experienced a dip of 2% in the number of qualifying deals dur...

Partner
Stephen Keogh
Article and Insights
6
Sep 2023
Welcome to the September 2023 edition of our Asset Management & Investment Funds U...

Partner
Patricia Taylor
Article and Insights
21
Dec 2022
The Central Bank of Ireland highlights the key prudential risks that will inform i...

Partner
Eoin Caulfield
Article and Insights
27
Jan 2023
William Fry is pleased to celebrate the Council of Europe's annual Data Protection...

Senior Associate
Rachel Hayes
Article and Insights
17
Feb 2023
On 16 February 2023, the Central Bank published a Dear CEO Letter addressing the C...

Partner
Shane Kelleher
Article and Insights
18
Mar 2020

Consultant
John Larkin
Report
8
Aug 2023
In line with international deal activity, Ireland’s mergers and acquisitions (M&A)...

Partner
Stephen Keogh
prev
next